František Dráfi

605 total citations
29 papers, 490 citations indexed

About

František Dráfi is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, František Dráfi has authored 29 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pharmacology and 7 papers in Rheumatology. Recurrent topics in František Dráfi's work include Pharmacological Effects of Natural Compounds (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Natural product bioactivities and synthesis (4 papers). František Dráfi is often cited by papers focused on Pharmacological Effects of Natural Compounds (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Natural product bioactivities and synthesis (4 papers). František Dráfi collaborates with scholars based in Slovakia, Italy and Czechia. František Dráfi's co-authors include Katarína Bauerová, Silvester Poništ, Viera Kuncírová, Danica Mihalová, Concetta Gardi, Alessandra Acquaviva, Blerta Stringa, Stefania Bilotto, L Bezáková and Idolo Tedesco and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

František Dráfi

27 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
František Dráfi Slovakia	13	215	99	76	76	61	29	490
Silvester Poništ Slovakia	17	319 1.5×	168 1.7×	142 1.9×	109 1.4×	83 1.4×	43	728
Viera Kuncírová Slovakia	10	141 0.7×	89 0.9×	71 0.9×	48 0.6×	44 0.7×	12	341
Ha‐Yong Yoon South Korea	8	240 1.1×	74 0.7×	55 0.7×	27 0.4×	92 1.5×	9	470
Atul Rawat India	16	341 1.6×	49 0.5×	68 0.9×	71 0.9×	59 1.0×	33	767
Mirka Laavola Finland	13	272 1.3×	42 0.4×	48 0.6×	46 0.6×	54 0.9×	14	595
Bin‐Feng Cheng China	17	409 1.9×	180 1.8×	41 0.5×	77 1.0×	73 1.2×	47	792
Yong‐Yu Yang China	15	456 2.1×	155 1.6×	29 0.4×	80 1.1×	60 1.0×	31	817
Seong Yeon Hwang South Korea	13	348 1.6×	32 0.3×	45 0.6×	75 1.0×	38 0.6×	24	639
Celia Vargas‐De‐La‐Cruz Peru	13	183 0.9×	47 0.5×	62 0.8×	40 0.5×	33 0.5×	40	459
Quan Jin China	19	366 1.7×	106 1.1×	20 0.3×	46 0.6×	66 1.1×	33	694

Countries citing papers authored by František Dráfi

Since Specialization

Citations

This map shows the geographic impact of František Dráfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by František Dráfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites František Dráfi more than expected).

Fields of papers citing papers by František Dráfi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by František Dráfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by František Dráfi. The network helps show where František Dráfi may publish in the future.

Co-authorship network of co-authors of František Dráfi

This figure shows the co-authorship network connecting the top 25 collaborators of František Dráfi. A scholar is included among the top collaborators of František Dráfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with František Dráfi. František Dráfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poništ, Silvester, Karol Švík, František Dráfi, et al.. (2025). Therapeutic Effects of Two Different Molecular Weights of Orally Administered Hyaluronan, Both as Monotherapy and in Combination with Methotrexate in a Rat Model of Arthritis. International Journal of Molecular Sciences. 26(9). 3958–3958.

Dráfi, František, et al.. (2024). Astaxanthin, Compared to Other Carotenoids, Increases the Efficacy of Methotrexate in Rat Adjuvant Arthritis. International Journal of Molecular Sciences. 25(16). 8710–8710. 3 indexed citations

Bauerová, Katarína, et al.. (2024). AB0783 A PRECLINICAL STUDY FOCUSSING ON OXIDATIVE STRESS IN ADJUVANT ARTHRITIS RAT MODEL TO EVALUATE THE EFFECT OF VARIOUS MOLECULAR WEIGHTS OF HYALURONIC ACID IN MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE. Annals of the Rheumatic Diseases. 83. 1684–1684. 1 indexed citations

Rocha, João, et al.. (2024). Comparative Analysis of Post‐Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023. Clinical Pharmacology & Therapeutics. 117(1). 73–93.

Dráfi, František, et al.. (2023). Crocus sativus L. Extract (Saffron) Effectively Reduces Arthritic and Inflammatory Parameters in Monotherapy and in Combination with Methotrexate in Adjuvant Arthritis. Nutrients. 15(19). 4108–4108. 7 indexed citations

Melchiorri, Daniela, et al.. (2023). Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?. Frontiers in Pharmacology. 14. 1196413–1196413. 32 indexed citations

Poništ, Silvester, et al.. (2022). Effect of Saffron Extract, Astaxanthin, and Carnosic Acid on the Levels of Matrix Metalloproteinase-9 and on Body Weight Changes in Arthritis Experiments. SHILAP Revista de lepidopterología. 69(2). 26–33. 2 indexed citations

Sepodes, Bruno, et al.. (2021). Implementation and Access to Pre-exposure Prophylaxis for Human Immunodeficiency Virus by Men Who Have Sex With Men in Europe. Frontiers in Medicine. 8. 722247–722247. 5 indexed citations

Babál, Pavel, František Dráfi, Silvester Poništ, et al.. (2021). Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis. International Journal of Molecular Sciences. 22(16). 8662–8662. 4 indexed citations

10.

Dráfi, František, et al.. (2019). Study of Anti-Inflammatory Activity of Fatsiphloginum™ (Fatsia japonica) and a New Purified Triterpene-Rich Extract of Saponins (PS-551) in Experimental Model of Arthritis. Physiological Research. 68(Suppl 1). S75–S85. 6 indexed citations

11.

Poništ, Silvester, František Dráfi, Viera Kuncírová, et al.. (2016). Effect of Carnosine in Experimental Arthritis and on Primary Culture Chondrocytes. Oxidative Medicine and Cellular Longevity. 2016(1). 8470589–8470589. 22 indexed citations

12.

Gardi, Concetta, Katarína Bauerová, Blerta Stringa, et al.. (2015). Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Archives of Biochemistry and Biophysics. 583. 150–157. 122 indexed citations

13.

Bauerová, Katarína, Silvester Poništ, Viera Kuncírová, et al.. (2014). Effect of Nonanimal High- and Low-Molecular-Mass Chondroitin Sulfates Produced by a Biotechnological Process in an Animal Model of Polyarthritis. Pharmacology. 94(3-4). 109–114. 14 indexed citations

14.

Bauerová, Katarína, Alessandra Acquaviva, Silvester Poništ, et al.. (2014). Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination. Autoimmunity. 48(1). 46–56. 29 indexed citations

15.

Dráfi, František, Katarína Bauerová, Viera Kuncírová, et al.. (2012). Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate. Interdisciplinary Toxicology. 5(2). 84–91. 18 indexed citations

16.

Bauerová, Katarína, Silvester Poništ, Danica Mihalová, František Dráfi, & Viera Kuncírová. (2011). Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress. Interdisciplinary Toxicology. 4(1). 33–9. 38 indexed citations

17.

Valachová, Katarína, Peter Rapta, Eva Hrabárová, et al.. (2011). Aurothiomalate as Preventive and Chain‐Breaking Antioxidant in Radical Degradation of High‐Molar‐Mass Hyaluronan. Chemistry & Biodiversity. 8(7). 1274–1283. 12 indexed citations

18.

Valachová, Katarína, Eva Hrabárová, František Dráfi, et al.. (2010). Ascorbate and Cu(II)-induced oxidative degradation of high-molar-mass hyaluronan. Pro- and antioxidative effects of some thiols.. PubMed. 31 Suppl 2. 101–4. 9 indexed citations

19.

Bauerová, Katarína, Ema Paulovičová, Danica Mihalová, et al.. (2010). Combined methotrexate and coenzyme Q₁₀ therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress.. Acta Biochimica Polonica. 57(3). 347–54. 45 indexed citations

20.

Dráfi, František, Katarína Bauerová, Katarína Valachová, et al.. (2010). Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo.. PubMed. 31 Suppl 2. 96–100. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact